KAHR medical

KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.

KAHR Medical ('KAHR') is pioneering the development of 'third generation biological drugs,' a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment options for cancer and autoimmune disorders.